(Q83622773)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Combination therapy for hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Norman M Kaplan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Cardiology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

270-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Treatment of hypertension in patients 80 years of age or older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Uric acid and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.31

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19352329

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2009.31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19352329%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference